Literature DB >> 8784563

Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

J A Englund1, P A Piedra, A Jewell, K Patel, B B Baxter, E Whimbey.   

Abstract

Although rapid antigen detection methods for the documentation of respiratory syncytial virus (RSV) infections are widely used with pediatric patients, these tests have not been prospectively evaluated in immunocompromised (IC) adults. For bone marrow transplant recipients and adult patients undergoing chemotherapy for leukemia who had recent onset of respiratory symptoms, respiratory samples (combined nasal wash [NW]-throat swab [TS], endotracheal tube [ET] aspirate, or bronchoalveolar lavage [BAL] samples) were collected for simultaneous culture and rapid antigen detection with the Directigen test kit (Becton Dickinson, Cockeysville, Md.). NW specimens from hospitalized pediatric patients with suspected RSV infection were also evaluated. Viral quantitation was performed on aliquots of the original specimens. A total of 539 samples from 372 adult patients were evaluated. RSV was isolated from 56 specimens (40 NW-TS, 7 ET aspirate, and 9 BAL specimens). By using culture as the "gold standard," rapid antigen detection had a sensitivity of 15% for adult NW-TS specimens, 71.4% for ET aspirate specimens, and 88.9% for BAL specimens; the specificity was > or = 97% for all specimen types. Significantly greater viral quantities were present in pediatric NW specimens than in adult NW specimens. In adults, more virus was present in BAL and ET aspirate specimens than in NW-TS specimens. Rapid detection of antigen respiratory samples obtained from the lower respiratory tracts of IC adults is sensitive and specific, but detection in upper respiratory tract samples is insensitive. The lower sensitivity of antigen detection in NW-TS specimens may be due to decreased viral load. A BAL specimen is more sensitive than an NW-TS specimen for the rapid diagnosis of RSV disease in IC adults.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784563      PMCID: PMC229088     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Clinically useful method for the isolation of respiratory syncytial virus.

Authors:  C B Hall; R G Douglas
Journal:  J Infect Dis       Date:  1975-01       Impact factor: 5.226

2.  Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus.

Authors:  J L Waner; N J Whitehurst; S J Todd; H Shalaby; L V Wall
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Respiratory syncytial virus pneumonia in a cardiac transplant recipient.

Authors:  J T Sinnott; J P Cullison; M S Sweeney; M Hammond; D A Holt
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

4.  Fatal syncytial virus pneumonia in a laminar airflow room.

Authors:  L R Crane; J A Kish; V Ratanatharathorn; J R Merline; M F Raval
Journal:  JAMA       Date:  1981 Jul 24-31       Impact factor: 56.272

Review 5.  Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature.

Authors:  M I Hertz; J A Englund; D Snover; P B Bitterman; P B McGlave
Journal:  Medicine (Baltimore)       Date:  1989-09       Impact factor: 1.889

Review 6.  Culture vs direct antigen assays for detection of microbial pathogens from lower respiratory tract specimens suspected of containing the respiratory syncytial virus.

Authors:  J A Kellogg
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

7.  Respiratory syncytial virus infection among intubated adults in a university medical intensive care unit.

Authors:  G G Guidry; C A Black-Payne; D K Payne; R M Jamison; R B George; J A Bocchini
Journal:  Chest       Date:  1991-11       Impact factor: 9.410

8.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.

Authors:  E Whimbey; R E Champlin; J A Englund; N Q Mirza; P A Piedra; J M Goodrich; D Przepiorka; M A Luna; R C Morice; J L Neumann
Journal:  Bone Marrow Transplant       Date:  1995-09       Impact factor: 5.483

9.  Respiratory syncytial virus infection in immunocompromised adults.

Authors:  J A Englund; C J Sullivan; M C Jordan; L P Dehner; G M Vercellotti; H H Balfour
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

10.  Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.

Authors:  J A Englund; L J Anderson; F S Rhame
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  58 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Multiplex RT-PCR and indirect immunofluorescence assays for detection and subtyping of human influenza virus in Tunisia.

Authors:  Manel Ben M'hadheb; Myriam Harrabi; Amira Souii; Nadia Jrad-Battikh; Jawhar Gharbi
Journal:  Curr Microbiol       Date:  2014-11-01       Impact factor: 2.188

3.  Evaluation of the Hexaplex assay for detection of respiratory viruses in children.

Authors:  S C Kehl; K J Henrickson; W Hua; J Fan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 4.  Respiratory Syncytial Virus Infection: An Illness for All Ages.

Authors:  Edward E Walsh
Journal:  Clin Chest Med       Date:  2016-12-27       Impact factor: 2.878

5.  Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses.

Authors:  Terho Heikkinen; Jane Marttila; Aimo A Salmi; Olli Ruuskanen
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Authors:  Susan M Bueno; Pablo A González; Kelly M Cautivo; Jorge E Mora; Eduardo D Leiva; Hugo E Tobar; Glenn J Fennelly; Eliseo A Eugenin; William R Jacobs; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

7.  Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus.

Authors:  Marilyn J Ohm-Smith; Patricia S Nassos; Barbara L Haller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples.

Authors:  C Moore; M Valappil; S Corden; D Westmoreland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

9.  Respiratory syncytial virus infection in children with severe motor and intellectual disabilities.

Authors:  S Onoyama; T Hoshina; S Honjo; K Ihara; T Hara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-17       Impact factor: 3.267

Review 10.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.